Mutations in SCO2 are associated with a distinct form of hypertrophic cardiomyopathy and cytochrome c oxidase deficiency

• Published in: Human molecular genetics 2000-03, Vol.9 (5), p.795-801
• Main Authors: JAKSCH, M, OGILVIE, I, JIANBO YAO, KORTENHAUS, G, BRESSER, H.-G, GERBITZ, K.-D, SHOUBRIDGE, E. A
• Format: Article
• Language: English
• Subjects: Amino Acid Sequence; Base Sequence; Biological and medical sciences; Cardiology. Vascular system; Cardiomyopathy, Hypertrophic - enzymology; Cardiomyopathy, Hypertrophic - genetics; Carrier Proteins; chromosome 22; DNA Primers; Electron Transport Complex IV - genetics; Female; Heart; Humans; Infant; Infant, Newborn; Male; Medical sciences; Mitochondrial Proteins; Molecular Sequence Data; Mutation; Myocarditis. Cardiomyopathies; Proteins - chemistry; Proteins - genetics; SCO2 gene; Sco2 protein
• ISSN: 0964-6906; 1460-2083; 1460-2083
• DOI: 10.1093/hmg/9.5.795

Mutations in SCO2, a cytochrome c oxidase (COX) assembly gene located on chromosome 22, have recently been reported in patients with fatal infantile cardio-encephalomyopathy and severe COX deficiency in heart and skeletal muscle. The Sco2 protein is thought to function as a copper chaperone. To investigate the extent to which mutations in SCO2 are responsible for this phenotype, a complete sequence analysis of the gene was performed on ten patients in nine families. Mutations in SCO2 were found in three patients in two unrelated families. We detected two missense mutations, one of which (G1541A) results in an E140K substitution adjacent to the highly conserved CxxxC metal-binding site. The other (C1634T) results in an R171W substitution more distant from the copper-binding site. A nonsense codon was found on one allele in two siblings presenting with a rapidly progressive fatal cardio-encephalomyopathy. Interestingly, all patients so far reported are compound heterozygotes for the G1541A mutation, suggesting that this is either an ancient allele or a mutational hotspot. The COX deficiency in patient fibroblasts (approximately 50%) did not result in a measurable decrease in the steady-state levels of COX complex polypeptide subunits and could be rescued by transferring chromosome 22, but not other chromosomes. These data indicate that mutations in SCO2 cause a fatal infantile mitochondrial disorder characterized by hypertrophic cardiomyopathy and encephalopathy, and point to the presence of one or more other genes, perhaps in the copper delivery pathway, in this clinical phenotype.